Bioventus (BVS) Selling, General & Administrative (2020 - 2026)
Bioventus (BVS) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.45 Bn | 175.15 Bn | 6.27 Bn | 3.74 Bn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 2.28 Bn |
| 3 | Medtronic | 108.03 Bn | 98.81 Bn | 6.41 Bn | 3.06 Bn |
| 4 | Boston Scientific | 68.19 Bn | 66.74 Bn | 3.61 Bn | 1.78 Bn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn | 522.20 Mn |
| 6 | Dexcom | 28.24 Bn | 27.13 Bn | 750.30 Mn | 349.70 Mn |
| 7 | GE HealthCare Technologies | 27.99 Bn | 25.70 Bn | 1.98 Bn | 1.12 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 23.72 Bn | 20.60 Bn | 2.07 Bn | -207.22 Mn |
| 10 | Bioventus | 829.43 Mn | 793.58 Mn | 90.77 Mn | 78.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 78.33 Mn |
| Dec 31, 2025 | 82.76 Mn |
| Sep 27, 2025 | 78.66 Mn |
| Jun 28, 2025 | 79.11 Mn |
| Mar 29, 2025 | 73.50 Mn |
| Dec 31, 2024 | 86.87 Mn |
| Sep 28, 2024 | 81.48 Mn |
| Jun 29, 2024 | 96.67 Mn |
| Mar 30, 2024 | 78.78 Mn |
| Dec 31, 2023 | 78.36 Mn |
| Sep 30, 2023 | 69.82 Mn |
| Jul 1, 2023 | 74.84 Mn |
| Apr 1, 2023 | 80.86 Mn |
| Dec 31, 2022 | 77.44 Mn |
| Oct 1, 2022 | 78.96 Mn |
| Jul 2, 2022 | 89.62 Mn |
| Apr 2, 2022 | 86.12 Mn |
| Dec 31, 2021 | 80.88 Mn |
| Oct 2, 2021 | 69.64 Mn |
| Jul 3, 2021 | 69.05 Mn |